We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Every pharmaceutical company wants to maximize speed to market for a new drug product. One way to enable this is with a platform approach for the package and delivery systems – in other words, to use the same vial containment system and/or syringe system for multiple drug products. To use this approach effectively, component and system performance data is needed. Through the Integrated Solutions platform, West is ideally positioned to provide this data.
As biosimilar development is expected to accelerate over the next decade, many customers are seeking packaging recommendations for these drug products. Because biosimilars are extremely sensitive to any changes from the innovator’s manufacturing and packaging processes, in every case it is important to understand the factors that affect the safety, purity and potency of the drug product as it relates to component selection.
As the adoption and acceptance of self-administered therapies grows, patients are spending less time with physicians and are playing a greater role in the delivery and management of their treatments. With the growing demand for extended-release and high-concentration formulations, more drug delivery systems choices are now available to differentiate drug products in a crowded market. Patient preferences can drive the selection of self-injection systems for a drug therapy. Selecting a system that patients prefer can, simplify use and increase compliance with the dosage regimen.
West is pleased to share a Q&A with Mark McElfresh, Vice President of Operations and Supply Chain at West contract manufacturing, that recently appeared in <em>Manufacturing Leadership Journal.</em><strong> </strong><strong><br></strong>
Quality. Technology. Trends in manufacturing. Injection systems. Primary containers. Global market trends. What does each of these areas have in common? Over the past decade tremendous progress has been made in drug delivery, but challenges continue.
West’s turns 100 today! A milestone that we are very proud of, and something few companies have the opportunity to celebrate. In honor of our 100th anniversary we are spotlighting our former President, Bill West, son of our founder Herman O. West.
English
Chinese
